Jupiter Neurosciences Stock Suffers 44% Plunge After Spiking to $11.14

Jupiter Neurosciences, Inc., a clinical-stage company, saw its stock experience an extreme swing on August 21, 2026. The shares opened at $8.20 and spiked to $11.14 before collapsing to close at $6.20.

The daily EMA structure remains bullish with price above the EMA20 (3.56), EMA50 (1.99), and EMA200 (1.08). However, RSI14 at 78.21 signals overbought conditions.

Despite the technically bullish trend, the recent session revealed distribution signals that challenge its sustainability. The company's market cap of just $5.0 million makes it prone to outsized moves on clinical news flow.